Article
Clinical observation on YiSuiShengXueGranule on treating 156 patients with beta-thalassemia major and the molecular mechanism study.
Biological & pharmaceutical bulletin - 1 Nov 2007
Fang Suping, Wu Zhikui, Zhang Xinhua, Liu Yongmei, Wang Wenjuan, Chai Limin, Cai Huiguo, Yi Jie, Wang Lei, Chen Yuying, Lv Xinxia, Huang Youwen, Wang Rongxin, Chen Peizhen
Abstract excerpt
OBJECTIVE: To investigate the clinical effects and security of YiSuiShengXueGranule (YSSXG) on treating 156 patients with beta-thalassemia major. METHODS: YSSXG was given orally to 156 patients with beta-thalassemia in GuangXi Autonomous Region (the high incidence area of beta-thalassemia in China) for 3 months as one therapeutic course, 3 times a day, 10 g each time (for children, the dose should be reduced...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.